Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan.

@article{Armstrong2017DriversOH,
  title={Drivers of Healthcare Costs Among the Costliest Patients With Psoriasis Over Three Years in a United States Health Plan.},
  author={April W Armstrong and Yang Zhao and Vivian Herrera and Yunfeng Li and Tim Bancroft and Michael E Hull and Aylin Altan},
  journal={Journal of drugs in dermatology : JDD},
  year={2017},
  volume={16 7},
  pages={651-658}
}
OBJECTIVE: To compare patients with psoriasis by cost level over 3 years. METHODS: Psoriasis patients in a large US health plan in 2011-2013 were identified. Four groups were created by healthcare costs excluding biologics: patients having top 10% of costs in all 3 years (Top), top 10% in 2 of 3 years (High), bottom 90% in 2 of 3 years (Medium), and bottom 90% in all 3 years (Bottom). Comorbidities, utilization, and costs between groups were compared. RESULTS: The study included 18,653 patients… CONTINUE READING

Citations

Publications citing this paper.

Similar Papers

Loading similar papers…